Thoracic sarcopenia predicts clinical outcomes in patients undergoing coronary artery bypass grafting: A 6-year

Zi-Le Shen1, Zhang Liu2, Wang-Fu Zang2

  • 1Department of Gastrointestinal Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Insights

Thoracic sarcopenia, a measure of muscle loss in the chest, predicts worse outcomes after coronary artery bypass grafting (CABG). Identifying this condition aids in preoperative risk assessment for better patient care.

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Geriatrics

Background:

  • The prognostic impact of thoracic sarcopenia on clinical outcomes following coronary artery bypass grafting (CABG) remains inadequately defined.
  • This study investigates the predictive value of thoracic sarcopenia for adverse events in CABG patients.

Purpose of the Study:

  • To assess the prognostic significance of thoracic sarcopenia in patients undergoing CABG.
  • To determine if thoracic sarcopenia is associated with increased postoperative complications and reduced overall survival.

Main Methods:

  • A cohort of 338 patients undergoing isolated CABG between December 2015 and May 2021 was analyzed.
  • Thoracic sarcopenia was assessed using skeletal muscle area at the T12 level, normalized from chest computed tomography (CT) scans.
  • Univariate and multivariate analyses were employed to identify risk factors for postoperative complications and overall survival (OS).

Main Results:

  • The prevalence of thoracic sarcopenia was 13.02% among the studied CABG patients.
  • Patients with thoracic sarcopenia exhibited significantly higher rates of major complications (81.8% vs. 61.9%), longer hospital and ICU stays, increased costs, and higher 30-day readmission rates.
  • Thoracic sarcopenia was independently associated with adverse postoperative complications and diminished long-term OS (2-year survival: 72.7% vs. 93.9% in non-sarcopenic patients).

Conclusions:

  • Thoracic sarcopenia serves as a robust clinical predictor for adverse postoperative complications and long-term overall survival in patients after CABG.
  • Incorporating thoracic sarcopenia assessment via chest CT into preoperative risk stratification for CABG is recommended.
Abstract

Related Concept Videos

Thoracic Aorta01:15

Thoracic Aorta

The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
822
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
50
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
38
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
62
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34